These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5723891)

  • 21. [Glucose/insulin response to a glucose overload in subjects at risk for type 2 diabetes].
    Ryder E; Gómez ME; Fernández V; Campos G; Morales LM; Valbuena H; Raleigh X
    Invest Clin; 2001 Dec; 42(4):269-81. PubMed ID: 11787271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the significance of the intravenous tolbutamide tolerance test in diagnosis of diabetes mellitus].
    Strauzenberg SE; Haller H
    Z Gesamte Inn Med; 1967 Apr; 22(7):Suppl:100-3. PubMed ID: 5599612
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypoglycemic insular tumors in adults. Biological and radiologic diagnosis].
    Laurent J; Debry G
    Presse Med (1893); 1969 Jan; 77(3):81-2. PubMed ID: 4307163
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of plasmatic values of glucose, FFA and insulin in subjects with progressive muscular dystrophy of the Duchenne type exposed to intravenous administration of tolbutamide].
    Falorni A; Lungarotti MS; Fracassini F; Massi-Benedetti F; Menegatti F
    Boll Soc Ital Biol Sper; 1969 Nov; 45(21):1365-9. PubMed ID: 5402387
    [No Abstract]   [Full Text] [Related]  

  • 25. [Composition of subcutaneous fat in macrosomatic newborn infants of diabetic and prediabetic mothers].
    Lupi L; Tiberio P; Ansanelli V; D'Avanzo M
    Pediatria (Napoli); 1967; 75(5):789-98. PubMed ID: 5603124
    [No Abstract]   [Full Text] [Related]  

  • 26. [The intravenous tolbutamide test in normal subjects].
    Czyzyk A; Kasperska T
    Diabete; 1965; 13(5):183-95. PubMed ID: 5841233
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tolbutamide test in certain pathologic conditions in children].
    Cutillo S; Iafusco F; Stoppoloni G; Pierantoni G
    Pediatria (Napoli); 1967; 75(2):243-59. PubMed ID: 5629003
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravenous glucose tolerance test in obesity.
    Vajpeyi GN; Nath K; Gupta AK; Kurup PN
    J Assoc Physicians India; 1968 Oct; 16(10):733-9. PubMed ID: 5715498
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study with tolbutamide and glibornuride for the diagnosis of latent diabetes mellitus].
    Wieser O; Iglauer E
    Wien Klin Wochenschr; 1972 Nov; 84(45):733-4. PubMed ID: 4634673
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatty acid turnover, substrate oxidation, and heat production in lean and obese cats during the euglycemic hyperinsulinemic clamp.
    Hoenig M; Thomaseth K; Waldron M; Ferguson DC
    Domest Anim Endocrinol; 2007 May; 32(4):329-38. PubMed ID: 16687234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired glucose tolerance and risk factors for progression to type 2 diabetes in youth.
    Weiss R
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():70-5. PubMed ID: 17991135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood glucose curves and peroral tolbutamide tests in the obese].
    Kazda A; Shameti H
    Cas Lek Cesk; 1969 Jul; 108(29):873-6. PubMed ID: 5794995
    [No Abstract]   [Full Text] [Related]  

  • 33. "When diabetes".
    Raheja BS; Talwalkar NG
    J Indian Med Assoc; 1968 Aug; 51(3):131-6. PubMed ID: 5731494
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the behavior of insulin activity and of the metabolites of fat metabolism in the serum in adiposis].
    Bottermann P; Schwarz K; Kopetz K
    Verh Dtsch Ges Inn Med; 1965; 71():464-7. PubMed ID: 5877658
    [No Abstract]   [Full Text] [Related]  

  • 35. [The peripheral utilization of glucose in essential infantile obesity].
    Gardoni L; Chiumello G; Cantone A
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:2045-7. PubMed ID: 5877124
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
    Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
    Dokken BB; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss.
    Corpeleijn E; Mensink M; Kooi ME; Roekaerts PM; Saris WH; Blaak EE
    Obesity (Silver Spring); 2008 May; 16(5):1025-32. PubMed ID: 18309299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamics of plasmatic free fatty acids in obese children and adolescents after oral administration of glucose].
    Popescu E; Popescu TA; Opincaru A
    Stud Cercet Endocrinol; 1971; 22(2):141-5. PubMed ID: 5566235
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin secretion in obesity.
    Kreisberg RA; Boshell BR; DiPlacido J; Roddam RF
    N Engl J Med; 1967 Feb; 276(6):314-9. PubMed ID: 6016291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.